Current Clinical Trials in Traumatic Brain Injury
Traumatic brain injury (TBI) is one of the leading causes of morbidity, disability and mortality across all age groups globally. Currently, only palliative treatments exist, but these are suboptimal and do little to combat the progressive damage to the brain that occurs after a TBI. However, multipl...
Main Author: | Zubair Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/12/5/527 |
Similar Items
-
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis
by: Honghao Huang, et al.
Published: (2022-12-01) -
The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial
by: Abolfazl Jokar, et al.
Published: (2017-02-01) -
Therapeutic efficacy of tranexamic acid on traumatic brain injury: a systematic review and meta-analysis
by: Jia-Xing Song, et al.
Published: (2024-03-01) -
CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
by: Dewan Yashbir, et al.
Published: (2012-06-01) -
Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury – meta-analysis of randomized controlled trials
by: Julius July, et al.
Published: (2020-04-01)